These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26348208)

  • 1. Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies.
    Parisi OI; Fiorillo M; Scrivano L; Sinicropi MS; Dolce V; Iacopetta D; Puoci F; Cappello AR
    Biomacromolecules; 2015 Oct; 16(10):3126-33. PubMed ID: 26348208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
    Cho YD; Park YJ
    Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
    Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO
    Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
    Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
    Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
    Do TT; Van Speybroeck M; Mols R; Annaert P; Martens J; Van Humbeeck J; Vermant J; Augustijns P; Van den Mooter G
    Int J Pharm; 2011 Jul; 414(1-2):118-24. PubMed ID: 21596119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal behavior of nano- and microsized fenofibrate: In vivo evaluation in man and in vitro simulation by assessment of the permeation potential.
    Hens B; Brouwers J; Corsetti M; Augustijns P
    Eur J Pharm Sci; 2015 Sep; 77():40-7. PubMed ID: 26004010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
    Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG
    Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
    Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
    Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release.
    Xia D; Cui F; Gan Y; Mu H; Yang M
    J Pharm Sci; 2014 Feb; 103(2):697-705. PubMed ID: 24375427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
    Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process.
    Ahn JB; Kim DH; Lee SE; Pyo YC; Park JS
    Int J Pharm; 2019 Jun; 564():263-272. PubMed ID: 31015003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and
    Gulati N; Kumar Chellappan D; Tambuwala M; A A Aljabali A; Prasher P; Kumar Singh S; Anand K; Sharma A; Kumar Jha N; Gupta G; Dua K; Dureja H
    Assay Drug Dev Technol; 2021; 19(4):246-261. PubMed ID: 33989048
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.
    O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT
    Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vivo evaluation of parenteral metoclopramide-loaded poly(alkylcyanoacrylate) nanospheres in rats.
    Radwan MA
    J Microencapsul; 2001; 18(4):467-77. PubMed ID: 11428676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization of undercooled liquid fenofibrate.
    Amstad E; Spaepen F; Weitz DA
    Phys Chem Chem Phys; 2015 Nov; 17(44):30158-61. PubMed ID: 26506141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of omega-3 phospholipid-based solid dispersion of fenofibrate for the enhancement of oral bioavailability.
    Yang L; Shao Y; Han HK
    Eur J Pharm Sci; 2015 Oct; 78():103-10. PubMed ID: 26165620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.